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Abstract: Considering premorbid or “peak” adult intelligence (IQ) is important when examining
post-stroke cognition. The stability of estimated premorbid IQ and its relationship to current cognitive
ability in stroke is unknown. We investigated changes in estimated premorbid IQ and current
cognitive ability up to three years post-stroke. Minor stroke patients (NIHSS < 8) were assessed at
one to three months, one and three years’ post-stroke. The National Adult Reading Test (NART)
and Addenbrooke’s Cognitive Examination-Revised (ACE-R) were used to estimate premorbid IQ
(NART IQ) and current cognitive ability respectively at each time-point. Baseline demographics,
vascular and stroke characteristics were included. Of the 264 patients recruited (mean age 66), 158
(60%), 151 (57%), and 153 (58%) completed cognitive testing at each time-point respectively. NART
IQ initially increased (mean difference (MD) = 1.32, 95% CI = 0.54 to 2.13, p < 0.001) before decreasing
(MD = −4.269, 95% CI = −5.12 to −3.41, p < 0.001). ACE-R scores initially remained stable (MD =
0.29, 95% CI = −0.49 to 1.07, p > 0.05) before decreasing (MD = −1.05, 95% CI = −2.08 to −0.01, p <
0.05). Adjusting for baseline variables did not change the relationship between NART IQ and ACE-R
with time. Increases in NART IQ were associated with more education. For ACE-R, older age was
associated with declines, and higher NART IQ and more education was associated with increases.
Across 3 years, we observed fluctuations in estimated premorbid IQ and minor changes in current
cognitive ability. Future research should aim to identify variables associated with these changes.
However, studies of post-stroke cognition should account for premorbid IQ.
Keywords: premorbid intelligence; NART; cognition; stroke
1. Introduction
Cognition in childhood determines cognitive ability in later life in healthy persons [1] and
influences cognition in those with dementia [2]. Therefore, it is important to consider peak adult
intelligence (IQ), also referred to as “premorbid IQ”, when assessing cognitive ability in later life
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to allow for the examination of cognitive decline [3]. Premorbid IQ refers to an individual’s level
of intellectual functioning prior to declines associated with ageing, neurological events, or both [4].
Declining cognitive ability in the years preceding the stroke can be measured with tests, such as the
Informant Questionnaire on Cognitive Decline (IQCODE) [5], but post-stroke cognitive impairment is
common and premorbid IQ is an important predictor [6,7]. Changes in cognitive ability are clinically
important, therefore, the availability of stable and reliable estimates of premorbid IQ are vital so that
we can accurately examine risk factors for post-stroke cognitive decline.
As actual IQ scores from early adulthood are rarely available, methods of estimation have been
developed. Widely accepted measures, such as the National Adult Reading Test (NART) [8], assess
vocabulary and pronunciation skills, which are considered as “crystallized intelligence” and remain
unaffected by neurological events or impairment [8]. Using the NART, premorbid IQ (NART IQ) can
be estimated based on the number of correct responses (NART score). The NART has been shown to
relate well to current IQ scores in healthy individuals [9] and to childhood IQ for individuals with and
without dementia [2]. It has been used in different neurological disorders [10] and has been shown to
have good consistency over periods up to 7.5 years [11,12]. However, some evidence suggests that it
can over- or under-estimate [9] and is less reliable in some patient populations [13].
To our knowledge, the stability of the NART after stroke has not been examined. Furthermore,
there is a scarcity of studies examining longitudinal changes in premorbid IQ (which should be stable)
and current cognitive ability (which declines with age).
We aimed to investigate:
1. Whether the NART is a valid test of premorbid IQ after stroke by examining the relationship
between time after stroke with changes in NART IQ, and current cognitive ability (i.e., how
do estimated premorbid IQ and current cognitive ability scores change between follow-up
time-points). We will also examine whether the relationships with time remain after controlling
for baseline demographic and stroke characteristics. Due to the obvious relationship between
age and time, we examine the relationship between age, estimated premorbid IQ and cognitive
ability at one to three months post-stroke.
2. Whether certain baseline demographic or stroke characteristics predict changes in NART IQ and
current cognition scores between two time-points post-stroke.
2. Materials and Methods
2.1. Recruitment
Patients (over 18 years) with recent minor ischemic stroke were recruited into the Mild Stroke
Study II (MSSII) between May 2010 and May 2012. This prospective study consecutively recruited in-
and outpatients with minor ischemic stroke admitted to the Lothian Stroke Services, Scotland. Patients
who were unable to consent (e.g., lacked capacity due to cognitive impairment), medically unlikely to
participate in long-term follow-up and had aphasia were excluded (details previously described) [7,14].
Minor ischemic stroke was defined as sudden onset of focal neurological symptoms lasting >24
hours, a National Institutes of Health Stroke Scale (NIHSS) score of <8, that was not expected to result
in long-term dependency (modified Rankin score (mRS) ≤ 3). Based on the clinical stroke syndrome
and MRI appearance of the acute lesion, the index stroke was classified as “cortical” or “lacunar” [15].
MRI including diffusion-weighted imaging (DWI) was performed using a 1.5 Tesla GE Sigma HDxt
scanner [14]. White matter hyperintensities (WMH) were rated using the Fazekas score [16], blind to
clinical and cognitive information [14].
2.2. Follow-Up Assessments
Following recruitment and baseline clinical assessment, patients were invited for cognitive
assessment at one to three months, and one and three years’ post-index stroke. Only those who were
seen for in-person assessment were offered cognitive assessment. Follow-up at one to three months
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and 1 year were performed in the hospital. At three years’, participants unable to attend the hospital
were offered a home visit or telephone interview.
We assessed premorbid IQ using the NART and current cognitive ability using the Addenbrooke’s
Cognitive Examination–Revised (ACE-R) [17] at all three time-points. The NART consists of 50
phonetically irregular words, which participants read aloud. The ACE-R is a multi-domain cognitive
screening tool used to identify those with cognitive impairment. Assessments were completed by
trained researchers, experienced in the administration of these neuropsychological screening tools.
In addition, we collected information relating to socio-demographic, vascular risk factors, lifestyle
variables, and recurrent vascular events including stroke [6].
This study was approved by the Lothian Ethics of Medical Research Committee (REC 09/81,
101/54) and the NHS Lothian Research and Development Office (2009/W/NEU/14). All participants
gave written informed consent at each time-point.
2.3. Statistical Analysis
Several methods of calculating premorbid IQ using NART errors scores are available. We
calculated “NART IQ” based on the number of correctly pronounced words on the NART using the
equation: 127.7 − 0.826 × (50 − NART score) [8]. Mild and severe cognitive impairment were defined
as ACE-R scores 83–88 and ≤82, respectively [17].
We used Wilcoxon rank-sum test (W), t-test and chi-square tests to compare those with NART
IQ and ACE-R versus those without (questionnaire only and no follow-up), tested at each time-point
based on demographics, lifestyle, and stroke characteristics.
2.3.1. Aim 1
We used a series of paired t-tests to examine whether NART IQ and ACE-R scores significantly
differed between one to three months and one year, and one and three years (mean differences (MD)).
We used linear mixed models to examine whether the associations between time and NART IQ or
ACE-R scores were affected by baseline characteristics (i.e., when adjusting for baseline factors, does
the association between time and NART IQ or ACE-R scores differ from that seen in paired t-tests). We
included baseline demographic (age, sex, and years of education), stroke characteristics (stroke subtype
(cortical/lacunar), stroke severity (NIHSS score, 0–8), Fazekas score (0–6)), and vascular and lifestyle
risk factors (hypertension (yes/no), smoking status (current and less than 1 year ex-smoker/more
than 1 year ex-smoker and never smoked)) factors. However, our models showed poor model fit:
Model residuals were non-normal (Figure S1) and could not be improved through standard data
transformations. Therefore, results should be interpreted with caution. Due to the obvious relationship
between age and time, we explored the relationships between NART IQ and ACE-R with age using
linear regression.
2.3.2. Aim 2
We examined predictors of change in NART IQ and ACE-R scores between each time-point by
including an interaction with time in our linear mixed effect models. To increase power, we examined
the interaction between time and each baseline demographic and stroke variable in separate models
resulting in a series of strongly related and overlapping models. It is important to note that we hoped
to identify effect which may be of interest in future research, therefore, we did not adjust for multiple
comparisons [18].
3. Results
3.1. Patient Characteristics
At baseline, 264 patients with minor ischemic stroke were included (mean age 66.40, SD 11.84,
154 (58.33%) male, Figure 1). Cognitive testing was offered to 208 (78.79%) at one to three months
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post-index stroke and 158 (59.85%) patients completed the assessment. Patients were followed-up for
cognitive assessment at one (151, 57.20%) and three years’ post-index stroke (153, 57.95%). Those with
cognitive follow-up had less severe stroke (one to three months), were younger, had more years of
education (both one year) and differed on smoking status (three years) compared to those without
cognitive follow-up. Additionally, those with cognitive follow-up at one year also had higher NART
IQ and ACE-R scores at one to three months and those with cognitive follow-up at three years had
higher one year ACE-R scores. There were no other significant differences in demographic or stroke
characteristics at each time-point (Table 1). Across all time-points, NART IQ scores ranged from 92.18
to 127.70/127.70 and ACE-R scores ranged from 54 to 100/100 (Table 2).
Figure 1. Flow chart showing number of participants with cognitive assessment (estimated premorbid,
current, or both) at each time-point in the Mild Stroke Study II (MSSII).
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Table 1. Baseline characteristics of patients with cognitive data by time-point.
One to Three Months (n = 158) 1 Year (n = 151) 3 Years (n = 153)
With vs. Without Cognitive Data With vs. Without Cognitive Data With vs. Without Cognitive Data
Demographics
Age at index stroke 65.09 ± 11.82 W = 9544.5 65.01 ± 11.02 W = 9845 * 65.50 ± 11.18 W = 9476.5
Sex: Male 93 (58.86%) χ2 = 0.007 93 (61.59%) χ2 = 1.242 83 (54.25%) χ2 = 2.115
Years of Education a 11.71 ± 2.94 W = 876.5 11.88 ± 3.02 W = 1098.5 * 12.04 ± 3.11 W = 2633
Smoker: χ2 = 2.954 χ2 = 7.551 χ2 = 12.256 *
Yes 48 (30.38%) 42 (27.81%) 43 (28.29%)
No 56 (35.44%) 58 (38.41%) 61 (40.13%)
Ex-smoker (for more than 1 year) 47 (29.75%) 44 (29.14%) 44 (28.95)
Ex-smoker (for less than 1 year) 7 (4.43%) 7 (4.64%) 4 (2.63)
Stroke Characteristics
Stroke subtype: χ2 = 0.287 χ2 = 0.998 χ2 = 0.224
Cortical 90 (56.96%) 88 (58.28%) 87 (56.86%)
Lacunar 68 (43.04%) 63 (41.72%) 66 (43.14%)
Stroke severity (NIHSS) 1.00 (1.00) W = 9853.5 * 1.00 (1.00) W = 9319.5 1.00 (2.00) W = 7709
Cognitive Variables
ACE-R 88.09 ± 8.17 - 88.93 ± 7.98 W = 815 **,b 88.32 ± 8.92 W = 2512/W = 1864 *,c
NART IQ 115.40 ± 8.60 - 117.56 ± 8.61 W = 1031 *,b 112.28 ± 8.40 W = 2549.5/W = 1998.5 c
a Collected at the 1-year follow-up; b baseline scores; c baseline/1-year follow-up scores; * p < 0.05; ** p < 0.001; W = Wilcoxon rank-sum test; χ2 = chi-square test; ACE-R = Addenbrooke’s
Cognitive Examination-Revised; NART IQ = Premorbid IQ estimated using The National Adult Reading Test.
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Table 2. NART IQ and ACE-R scores at and between each time-point for all patients with data available at each time-point.
Scores Change in Scores
1–3 Months 1 Year 3 Years 1–3 Months to 1 Year 1 to 3 Years 1–3 Months to 3 Years
NART IQ
n 154 140 153 n 124 101 100
Mean ± SD
(range)
115.40 ± 8.60
(92.18–127.70)
117.56 ± 8.61
(93.08–127.70)
112.28 ± 8.40
(92.18–127.70) Mean change (95% CI)
1.322
(0.54 to 2.13) **
−4.269
(−5.12 to −3.41) **
−3.155
(−3.99 to 2.32) **
Decreased n (%) 35 (28.23%) 82 (81.19%) 78 (78.00%)
Increased n (%) 77 (62.10%) 12 (11.88%) 15 (15.00%)
No change n (%) 12 (9.68%) 7 (6.93%) 7 (7.00%)
ACE-R
n 157 151 151 n 135 106 101
Mean ± SD (range) 88.09 ± 8.17(59.00–100.0)
88.93 ± 7.98
(59.00–100.0)
88.32 ± 8.92
(54.00–100.0) Mean change (95% CI)
0.289
(−0.49 to 1.07)
−1.047
(−2.08 to −0.01) *
−0.178
(−1.35 to 1.00)
No impairment n (%) a 91 (57.96%) 91 (60.26%) 85 (56.29%) Decreased n (%) 54 (40.00%) 57 (53.77%) 42 (41.58%)
Mild impairment n (%) b 28 (17.83% 28 (18.54%) 35 (23.18%) Increased n (%) 61 (45.19%) 42 (39.62%) 48 (47.52%)
Severe impairment n (%) c 38 (24.20%) 32 (21.19%) 31 (20.53%) No change n (%) 20 (14.81%) 7 (6.60%) 11 (10.89%)
* p < 0.05; ** p < 0.001; a ACE-R scores ≥ 89; b ACE-R scores 83–88; c ACE-R scores ≤ 82.
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3.2. Aim 1: Changes in Estimated Premorbid IQ and Current Cognitive Ability over Time
3.2.1. NART IQ
Estimated premorbid IQ (NART IQ) changed significantly between all three time-points (Table 2,
Figure 2a). Between one to three months and one year (n = 124), NART IQ significantly increased by
a MD of 1.332 points (95% CI 0.536 to 2.129, p = 0.001). During this period, 77/124 (62%) improved,
35/124 (28%) declined, and 12/124 (10%) did not change.
Figure 2. NART IQ and ACE-R scores by time-point (a) NART IQ scores by time-point for patients
with data available at each time-point. (b) ACE-R scores by time-point for patients with data available
at each time-point. (c) NART-IQ scores by time-point for patients with data available at all three
time-points. (d) ACE-R scores by time-point for patients with data available at all three time-points.
Between one and three years (n = 101), NART IQ decreased significantly by −4.269 points (95% CI
−5.124 to −3.414, p < 0.001). During this period, 12/101 (12%) improved, 82/101 (81%) declined, and
7/101 (7%) did not change.
Overall, between one to three months and three years (n = 100), NART IQ decreased significantly
(−3.155, 95% CI −3.991 to −2.319, p < 0.001). The majority (78/100, 78%) of participants showed
a decline.
The associations between time and NART IQ scores after controlling for baseline and stroke
characteristics remained significantly positive (b = 1.453, 95% CI = 0.657 to 2.270, p < 0.001) at one to
three months and one year, and significantly negative at one and three years (b = −4.474, 95% CI=
−5.345 to −3.631, p < 0.001, Table 3)
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Table 3. Linear mixed effects model showing the associations between time and NART IQ and ACE-R
adjusted for baseline characteristics.
1–3 Months and 1 Year 1–3 Years
B 95% CI p B 95% CI p
NART IQ
Time (years) 1.453 (0.657, 2.270) <0.001 −4.474 (−5.345, −3.631) <0.001
Age 0.100 (−0.026, 0.225) 0.118 0.099 (−0.039, 0.237) 0.170
Sex (male) 1.232 (−1.222, 3.587) 0.316 1.497 (−1.005, 3.999) 0.253
Baseline Fazekas 0.166 (−0.639, 0.973) 0.692 −0.002 (−0.870, 0.865) 0.996
Stroke subtype (lacunar) 1.047 (−1.401, 3.495) 0.413 0.893 (−1.721, 3.508) 0.514
NIHSS −0.214 (−1.306, 0.877) 0.707 0.032 (−1.120, 1.182) 0.958
Hypertension (yes) 2.815 (0.222, 5.409) 0.075 2.304 (−0.466, 5.075) 0.112
Smoker (yes) −0.536 (−3.158, 2.086) 0.696 −1.574 (−4.397, 1.251) 0.287
Years of education 1.287 (0.877, 1.697) <0.001 1.193 (0.775, 1.612) <0.001
ACE-R
Time (years) 0.403 (−0.375, 1.195) 0.312 −1.028 (−2.039, −0.003) 0.047
Age −0.194 (−0.308, −0.080) 0.001 −0.162 (−0.292, −0.032) 0.017
Sex (male) 0.362 (−1.758, 2.479) 0.743 0.392 (−1.947, 2.732) 0.749
Baseline Fazekas −0.316 (−1.039, 0.410) 0.403 −0.692 (−1.499, 0.114) 0.101
Stroke subtype (lacunar) 0.728 (−1.474, 2.927) 0.526 1.376 (−1.070, 3.825) 0.282
NIHSS −0.421 (−1.398, 0.556) 0.410 −0.316 (−1.382, 0.749) 0.571
Hypertension (yes) 3.709 (1.380, 6.037) 0.002 3.465 (0.864, 6.066) 0.011
Smoker (yes) −0.355 (−2.716, 2.009) 0.772 −0.182 (−2.819, 2.461) 0.895
Years of education 0.952 (0.581, 1.322) <0.001 1.009 (0.615, 1.404) <0.001
NART IQ = Premorbid IQ estimated using the National Adult Reading Test; ACE-R = Addenbrooke’s Cognitive
Examination-Revised. Results in italics highlight the estimates of interest showing that the relationships between
time and changes in NART-IQ and ACE-R remain after adjusting for baseline characteristics.
3.2.2. ACE-R
Current cognitive ability (ACE-R) remained generally more stable across all three time-points
(Table 2 and Figure 2b). Between one to three months and one year (n = 135), ACE-R scores did not
change significantly (0.289, 95% CI −0.488 to 1.065, p = 0.463). During this period, 61/135 (45%) patients
improved, 54/135 (40%) declined, and 20/135 (15%) did not change.
Between one and three years (n = 106), ACE-R scores declined significantly (−1.047, 95% CI −2.082
to −0.012, p = 0.047). During this period, 42/106 (40%) patients improved, 57/106 (54%) declined, and
7/106 (7%) did not change.
Overall, between one to three months and three years (n = 101), 48/101 (48%) improved, 42/101
(16%) declined, and 11/101 (10%) did not change, however the overall change was not significant (0.178,
95% CI −1.354 to 0.997, p = 0.764).
The associations between time and ACE-R scores remained unchanged after controlling for
baseline and stroke characteristics: Positive, but non-significant, at one to three months and one year
(b = 0.403, 95% CI = −0.375 to 1.195, p = 0.312) and significantly negative at one and three years (b =
−1.028, 95% CI = −2.039 to −0.003, p = 0.047, Table 3).
3.2.3. Sensitivity Analysis
Including only patients with cognitive data at all three time-points did not change the patterns of
NART IQ (n = 90) and ACE-R (n = 96) scores (Tables S1 and S2 and Figure 2c,d).
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3.2.4. The Relationship between Age and Estimated Premorbid IQ (NART IQ) and Current Cognitive
Ability (ACE-R)
The relationship between age with NART IQ and ACE-R scores were in different directions. Age
was positively associated with NART IQ at one to three months post-stroke (i.e., there was a trend
for those with older age at entry into study having higher NART IQ), however this association was
non-significant (b = 0.069, 95% CI = −0.048 to 0.181, p = 0.24, Figure 3). For ACE-R, the relationship
between age and ACE-R was negative (i.e., older age at entry into study was associated with lower
current cognitive ability). This association was significant (b = −0.210, 95% CI = −0.314 to −0.107, p <
0.001, Figure 3).
Figure 3. The relationship between NART IQ and ACE-R with age at first assessment at between one
to three months.
3.3. Aim 2: Predictors of Changes between Time-Points
3.3.1. NART IQ
More years of education was associated with increases in NART IQ between one to three months
and one year (b = 1.165, 95% CI = 0.721 to 1.608), p < 0.001), and smaller decreases between one and
three years’ (b = 1.046, 95% CI = 0.598 to 1.495, p < 0.001). There were no other significant interactions
suggesting that no other baseline demographics or stroke characteristics were associated with changes
in NART IQ (Table 4 and Table S3).
3.3.2. ACE-R
Older age was associated with declines in ACE-R scores between one to three months (b = −0.202,
95% CI = −0.311 to −0.093, p < 0.001), and one and three years’ (b = −0.137, 95% CI = −0.255 to −0.019, p
= 0.024). Increases in ACE-R were associated with higher NART IQ (one to three months and one year:
b = 0.345, 95% CI = 0.229 to 0.461, p < 0.001, one and three years: b = 0.416, 95% CI = 0.286 to 0.546, p <
0.001) and more education (one to three months and one year: b = 0.603, 95% CI = 0.229 to 0.977, p =
0.002, and one and three years: b = 0.501, 95% CI = 0.113 to 0.888, p = 0.012). In addition, increases in
ACE-R between one to three months and one year were associated with having hypertension (b = 2.943,
95% CI = 0.605 to 5.280, p = 0.014). There were no other significant interactions (Table 5 and Table S4).
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Table 4. Linear mixed effects models showing factors associated with changes in NART IQ at each time-point.
Variable
Variation in NART IQ with Variable at: Change in NART IQ between: Change in NART IQ with Variable at:
1–3 Months 1–3 Months and 1 Year 1 Year
B 95% CI p B 95% CI p B 95% CI p
Age 0.095 (−0.038, 0.229) 0.160 1.339 (−3.545, 6.223) 0.588 0.097 (−0.039, 0.233) 0.160
Sex 1.546 (−0.998, 4.090) 0.231 1.878 (0.582, 3.173) 0.005 0.847 (−1.760, 3.453) 0.521
Baseline Fazekas 0.402 (−0.458, 1.262) 0.357 2.954 (1.306, 4.602) <0.001 −0.123 (−1.004, 0.758) 0.782
Stroke subtype (lacunar) 0.704 (−1.926, 3.334) 0.597 1.122 (0.035, 2.210) 0.043 1.454 (−1.238, 4.145) 0.287
NIHSS −0.340 (−1.513, 0.833) 0.567 1.163 (0.066, 2.260) 0.038 −0.062 (−1.253, 1.130) 0.918
Hypertension (yes) 2.970 (0.162, 5.778) 0.038 1.695 (0.121, 3.269) 0.035 2.642 (−0.222, 5.506) 0.070
Smoker (yes) −0.256 (−3.073, 2.562) 0.858 1.672 (0.692, 2.651) 0.001 −0.957 (−3.836, 1.923) 0.512
Years of education 1.400 (0.958, 1.842) <0.001 4.277 (1.060, 7.494) 0.010 1.165 (0.721, 1.608) <0.001
1 Year 1 and 3 Years 3 Years
Age 0.098 (−0.061, 0.257) 0.223 −2.107 (−4.706, 0.492) 0.111 0.0963 (−0.050, 0.243) 0.194
Sex 1.214 (−1.866, 4.293) 0.436 −2.327 (−2.997, −1.657) <0.001 1.3677 (−1.345, 4.081) 0.319
Baseline Fazekas −0.242 (−1.281, 0.797) 0.644 −2.633 (−3.551, −1.716) <0.001 −0.103 (−1.035, 0.828) 0.826
Stroke subtype (lacunar) 2.980 (−0.160, 6.119) 0.063 −1.723 (−2.283, −1.164) <0.001 1.842 (−0.979, 4.663) 0.198
NIHSS 0.213 (−1.166, 1.592) 0.760 −2.129 (−2.727, −1.531) <0.001 0.116 (−1.122, 1.354) 0.852
Hypertension (yes) 2.012 (−1.383, 5.406) 0.242 −2.36 (−3.215, −1.505) <0.001 2.176 (−0.815, 5.168) 0.152
Smoker (yes) −1.051 (−4.446, 2.344) 0.540 −2.152 (−2.658, −1.646) <0.001 −1.369 (−4.393, 1.656) 0.371
Years of education 0.873 (0.375, 1.372) 0.001 −4.332 (−6.003, −2.661) <0.001 1.046 (0.598, 1.495) <0.001
All estimates are adjusted for the other variables in the model. Each row represents an individual, but strongly related, overlapping model. Full tables for each model can be found in
Table S3.
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Table 5. Linear mixed effects models showing factors associated with changes in current ACE-R scores at each time point.
Variable
Variation in ACE-R with Variable at: Change in ACE-R between: Change in ACE-R with Variable at:
1–3 Months 1–3 Months and 1 Year 1 Year
B 95% CI p B 95% CI p B 95% CI p
Age −0.239 (−0.345, −0.133) <0.001 −2.191 (−7.337, 2.954) 0.401 −0.202 (−0.311, −0.093) <0.001
Sex (male) −0.370 (−2.417, 1.677) 0.721 −0.001 (−1.389, 1.387) 0.999 −0.030 (−2.150, 2.090) 0.977
Baseline Fazekas −0.221 (−0.915, 0.473) 0.529 0.207 (1.597, 2.011) 0.820 −0.222 (−0.937, 0.494) 0.541
Stroke subtype (lacunar) −0.327 (−2.433, 1778) 0.759 −0.020 (−1.177, 1.137) 0.973 0.191 (−1.995, 2.377) 0.863
NIHSS −0.609 (−1.541, 0.323) 0.198 −0.536 (−1.683, 0.612) 0.357 0.115 (−0.840, 1.070) 0.812
Hypertension (yes) 2.761 (0.499, 5.033) 0.018 0.073 (−1.601, 1.746) 0.932 2.943 (0.605, 5.280) 0.014
Smoker (yes) 0.388 (−1.859, 2.635) 0.733 0.595 (−0.452, 1.642) 0.263 −0.835 (−3.165, 1.494) 0.479
NART IQ 0.290 (0.171, 0.408) 0.000 −6.217 (−18.303, 5.869) 0.310 0.345 (0.229, 0.461) <0.001
Years of education 0.407 (0.026, 0.788) 0.037 −2.157 (−5.616, 1.302) 0.219 0.603 (0.229, 0.977) 0.002
1 Year 1 and 3 Years 3 Years
Age −0.054 (−0.196, 0.087) 0.447 5.771 (2.560, 8.981) 0.001 −0.137 (−0.255, −0.019) 0.024
Sex (male) 1.016 (−1,928, 3.960) 0.495 0.803 (−0.114, 1.720) 0.085 0.370 (−1.882, 2.622) 0.745
Baseline Fazekas −0.123 (−1.088, 0.842) 0.801 1.250 (0.018, 2.482) 0.047 −0.407 (−1.167, 0.353) 0.291
Stroke subtype (lacunar) −1.008 (−3.990, 1.974) 0.504 <0.001 (−0.783, 0.783) 0.999 0.022 (−2.291, 2.335) 0.985
NIHSS 0.227 (−1.063, 1.517) 0.727 0.683 (−0.138, 1.504) 0.102 −0.005 (−1.011, 1.000) 0.992
Hypertension (yes) 2.378 (−0.875, 5.632) 0.150 0.444 (−0.709, 1.598) 0.446 2.367 (−0.108, 4.843) 0.061
Smoker (yes) −1.491 (−4.670, 1.689) 0.354 0.089 (−0.619, 0.796) 0.804 −0.226 (−2.697, 2.245) 0.856
NART IQ 0.380 (0.211, 0.549) <0.001 −3.704 (−11.427, 4.020) 0.343 0.416 (0.286, 0.546) <0.001
Years of education 0.548 (0.064, 1.032) 0.027 1.019 (−1.312, 3.350) 0.387 0.501 (0.113, 0.888) 0.012
All estimates are adjusted for the other variables in the model. Each row represents an individual, but strongly related, overlapping model. Full tables for each model can be found in
Table S4.
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4. Discussion
We assessed patients with minor ischaemic stroke over a follow-up period of three years assessing
the stability of both estimated premorbid IQ and current cognitive ability using established measures.
To our knowledge, this is the first study to assess the stability of the NART post-stroke and one of a few
studies to assess current cognition to three years post-stroke. Our findings suggest that post-stroke
cognitive change is complex. We show fluctuations in NART IQ scores with a significant increase
between one to three months and one year, followed by a significant decrease between one and three
years’ post-index stroke. For ACE-R scores, we found that scores remained mostly stable between first
assessment at between one to three months and second assessment at one year, followed by a small,
but significant, decrease by the third assessment at three years. Adjusting for baseline demographic
and stroke characteristics did not change these trajectories. Increases in both NART IQ and ACE-R
scores post-stroke were associated with more education. Additionally, higher NART IQ and older
age were associated with changes in ACE-R scores (increases and decreases respectively). Despite
including relevant outcome predictors (e.g., age, stroke severity, WMH volume etc.), the poor model fit
may reflect the lack of relevant variables that contribute to cognitive ability scores. This highlights
the need for future research closely examining variables associated with changes in both estimated
premorbid and current cognitive ability to better understand post-stroke cognitive trajectories.
The stability of the NART in other conditions has shown mixed findings. Although, the NART
has been shown to be a stable estimate of premorbid IQ in healthy individuals [19] and patients
with schizophrenia (mean age 35 years) [11] over one and 7.5 years respectively, small but significant
decreases have been shown in healthy older individuals [20] and those with dementia [21]. Furthermore,
improvements in NART performance has also been shown in traumatic brain injury (TBI) [22,23]
demonstrating the complex interaction of disease variables, age, education and time post-injury
affecting NART performance.
Symptoms such as post-stroke fatigue and speech disturbances are common [24,25] and may
affect NART performance shortly after stroke. Symptom improvement may explain the initial increase
in NART IQ, however these variables would also affect ACE-R performance, which is not seen
here. Furthermore, factors associated with declining NART performance, such as increasing rates of
dementia, were not frequently observed in our study and recurrent stroke between the one and three
year follow-up was uncommon (n = 12, 8%).
We show only a small, albeit significant, decrease in current cognitive ability (ACE-R) between
one and three years’. Although cognitive ability declines with increasing age [26,27] and post-stroke
dementia is common [28], studies show mixed post-stroke cognitive trajectories [29]. Improvements in
global cognition are seen in some studies with short follow-up periods (up to three months) [30], while
those with longer follow-up periods (up to six years) report declines [31].
We show a significant negative relationship between age and current cognitive ability, however
the association between NART IQ and age is less clear. Research in individuals from the general
population has shown better crystallized intelligence in older adults [32], although some studies have
demonstrated a negative relationship between age and NART [13]. We show a weak, non-significant,
positive association such that individuals entered into the study having had a stroke at older ages had
marginally higher NART IQ, although this association was non-significant. If true in other studies of
post-stroke cognition, then age is a source of confounding and variation in premorbid IQ may account
for poor prediction of post-stroke cognitive impairment.
We did not find that adjusting for demographic and stroke characteristics, including age, altered
the association between time and changes in ACE-R and NART IQ. This suggests that other unidentified
factors are contributing to this pattern of results. Future research should focus on the identification
of factors influencing longitudinal changes in premorbid IQ in stroke patients to enable the accurate
prediction and identification of those at risk of poor post-stroke cognitive outcomes.
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Strengths and Limitations
Although the MSSII achieved good follow-up at all three time-points, we found some evidence of
possible participation bias as those with follow-up had better previous ACE-R and NART IQ scores.
This may have contributed to the overall stability of current cognitive ability, however the trends
in both NART IQ and ACE-R scores remained the same when only those with cognitive data at all
time-points were examined and when accounting for baseline demographic and stroke characteristics.
Furthermore, we used linear mixed effect models to examine factors associated with change which
is unaffected by missing data points and accounts for different starting points (i.e., someone who
decreases from NART IQ of 120 to 117 is not necessarily the same as someone who decreases from 90
to 97).
Cognitive assessment were administered by one rater at one to three months and one year and
different raters at three years’ which may have resulted in some variability. This is particularly true with
the NART, which relies on the subjective assessment of correct pronunciation, however the inter-rater
reliability of the NART has previously shown to be good [22,33,34] and all researchers administering
the assessments had undergone the same training.
5. Conclusions
Overall, we show an interesting dichotomy with declines in estimates of premorbid IQ, while
current cognitive ability scores remain more stable. These findings suggest caution in the use of
the NART to estimate premorbid IQ after stroke, although its use is more beneficial than having no
measure. Future research in post-stroke cognition should try to account for premorbid IQ since it is a
major predictor of post-stroke cognition and health in general and should closely examine what factors
influence changes in premorbid IQ following stroke so that more reliable estimates can be obtained.
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Figure S1: Residual plots for linear mixed models examining the associations between time, demographic and
vascular risk factors with NART IQ and ACE-R scores by time-point, Table S1: NART IQ and ACE-R scores at each
time-point for patients with data available at all time-points, Table S2: Linear mixed effects model showing the
associations between time and NART IQ and ACE-R adjusted for baseline characteristics for patients with data
available at all time-points, Table S3: Full linear mixed effects models showing factors associated with changes in
NART IQ at each time-point, Table S4: Full linear mixed effects models showing factors associated with changes
in current ACE-R scores at each time-point.
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